SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Interim Management Statement

9 May 2013 07:00

RNS Number : 2866E
Tullett Prebon PLC
09 May 2013
 

9 May 2013

 

Tullett Prebon plc

 

AGM Statement and Interim Management Statement

 

Tullett Prebon plc (the "Company") is today issuing its Interim Management Statement in relation to the period from 1 January 2013. This statement will be delivered to those attending the Annual General Meeting today.

 

Business Update

 

As expected, market conditions have continued to be challenging. The level of activity in the world's financial markets has remained subdued reflecting persistently low volatility. Market volumes also continue to be adversely affected by the more onerous regulatory environment applicable to many of our customers, and by the considerable uncertainty over the impact of new regulations covering the OTC markets, both of which reduce our customers' ability and willingness to trade.

 

Revenue in the four months to April was £293m, 4% lower than reported for the equivalent period last year. At constant exchange rates revenue was also 4% lower.

 

The business has continued to develop its hybrid electronic broking offering to comply with regulatory requirements and to respond to market demand. We are well prepared for the implementation in the USA of the rules relating to swap and security-based swap execution facilities, and we intend to launch platforms in the USA for those products which are within the scope of the rules after those rules have been published in final form.

 

We have recently finalised the terms of a participation agreement under which a minimum of 12 leading banks will supply electronic streaming liquidity for Euro interest rate derivatives through tpSWAPDEAL, our interest rate swap platform.

 

Legal action continues to be pursued against BGC and former employees in the USA in response to the raid on the business by BGC in the second half of 2009. The FINRA arbitration on the claim brought by the subsidiary companies in the United States directly affected by the raid is expected to continue through the first half of this year. The outcome of the arbitration is expected to be determined before the end of the year. A separate action is being pursued by the Company and the directly affected subsidiaries in the New Jersey Superior Court, alleging, among other causes of action, violations under the NJ RICO Act. Discovery is ongoing and no trial date has been set. Since 1 January, £6.8m of costs have been incurred in relation to these actions. Consistent with the treatment adopted in 2012, these costs will be recognised as an exceptional charge in the 2013 accounts.

 

On 19 April the Company entered into a new three year £150m revolving credit facility replacing the previous bank facilities. All the outstanding bank term debt under the previous facility has now been repaid. The Company's financial position remains strong.

 

 

 

Enquiries:

 

Nigel Szembel, Head of Communications, Tullett Prebon plc

Direct: +44 (0)20 7200 7722

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDUIGGBGXI
Date   Source Headline
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20254:30 pmRNSHolding(s) in Company
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:01 amRNSLaunch of fifth share buyback programme of £30m
6th Aug 20257:00 amRNSHalf-year Report
16th Jul 20255:30 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20252:00 pmRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20254:00 pmRNSDirector/PDMR Shareholding
4th Jun 20253:45 pmRNSDirector/PDMR Shareholding
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20254:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.